Suri Biotech Company
Suri Biotech is a biotechnology company, developing health-promoting bacterial strains with targeted mechanisms of action for the alleviation of bloating and intestinal discomfort.
The company's proprietary strains reduce the production of hydrogen gas by intestinal microorganisms – with potential applications in multiple functional gastrointestinal disorders (e.g. infant colic, lactose intolerance, bloating).
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2020-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 78 618 53 12
Investors:
Swissnex San Francisco, Venture Kick
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland


